Sangamo Therapeutics (SGMOQ) Capital Expenditures (2010 - 2025)
Sangamo Therapeutics (SGMOQ) posted quarterly Capital Expenditures of $14000.0 for Q4 2025, up 109.15% year-over-year from $6693.8 in Q4 2024, and down 78.12% quarter-over-quarter from $64000.0 in Q3 2025.
Sangamo Therapeutics (SGMOQ) Capital Expenditures (2010 - 2025) Analysis & Trends
Sangamo Therapeutics' Capital Expenditures history runs 16 years deep, the most recent figure standing at $14000.0 for Q4 2025.
- In Q4 2025, Capital Expenditures rose 109.15% year-over-year to $14000.0; the TTM figure through Dec 2025 stood at $102000.0 (down 56.78% YoY), while the FY2025 annual figure was $102000.0, down 56.78% from the prior year.
- Capital Expenditures for Q4 2025 stood at $14000.0, down from $64000.0 in the prior quarter.
- The five-year high for Capital Expenditures was $12.3 million in Q2 2021, with the low at -$5.3 million in Q2 2023.
- The 5-year median for Capital Expenditures is $311500.0 (2024), against an average of $2.2 million.
- Peak annual rise in Capital Expenditures reached 351.93% in 2023, while the deepest fall reached 21064.0% in 2023.
- Sangamo Therapeutics' Capital Expenditures stood at $2.9 million in 2021, then soared by 161.51% to $7.5 million in 2022, then tumbled by 130.91% to -$2.3 million in 2023, then soared by 93.38% to -$153000.0 in 2024, then soared by 109.15% to $14000.0 in 2025.
- Business Quant data shows SGMOQ's Capital Expenditures at $14000.0 in Q4 2025, $64000.0 in Q3 2025, and -$210000.0 in Q2 2025.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 14,000.00 |
| Dec 31, 2025 | 14,000.00 |
| Sep 30, 2025 | 64,000.00 |
| Sep 30, 2025 | 64,000.00 |
| Jun 30, 2025 | -210,000.00 |
| Jun 30, 2025 | -210,000.00 |
| Mar 31, 2025 | 234,000.00 |
| Mar 31, 2025 | 234,000.00 |
| Dec 31, 2024 | -153,000.00 |
| Dec 31, 2024 | -153,000.00 |
| Sep 30, 2024 | 389,000.00 |
| Sep 30, 2024 | 389,000.00 |
| Jun 30, 2024 | -460,000.00 |
| Jun 30, 2024 | -460,000.00 |
| Mar 31, 2024 | 460,000.00 |
| Mar 31, 2024 | 460,000.00 |
| Dec 31, 2023 | -2.31 Mn |
| Dec 31, 2023 | -2.31 Mn |
| Sep 30, 2023 | -2.15 Mn |
| Sep 30, 2023 | -2.15 Mn |